Erlend Petter Skagseth • 1955 • Paradis • 16 roles • 8 shareholdings

This website uses cookies to enhance the user experience.

Roles

Boards

Name	Role	Total operating income	Total equity	Shares
M MITOSIS AS	Contact Person	-	5,454,063	100 % directly
S SARSIA IV AS	Chairman	-	-31,888	15.77 % indirectly
A APIM THERAPEUTICS AS	Chairman	64,960	20,194,781	0.91 % indirectly
R RECCURA THERAPEUTICS AS	Chairman	-	774,508	-
S SERCA PHARMACEUTICALS AS	Chairman	4,714,624	27,645,238	-
A AVEXXIN ONCOLOGY AS	Chairman	-	-78,133	-
S STIFTELSEN SINTEF	Alternate Member	369,543,000	3,199,895,000	-
S SEAFARM SOLUTIONS AS	Board Member	152,750	1,347,958	-
C CONNECT VEST	Board Member	5,257,202	1,938,608	-
B BOLIGSAMEIET ST. OLAVS VEI 25	Board Member	-	-	-
C CAEDO ONCOLOGY AS	Chairman	-	28,581,779	-
S SINTEF AS	Alternate Member	2,710,260,013	837,850,205	-
S SARSIA FOND III AS	Board Member	-	54,658,348	-
C CALLUNA PHARMA POOLCO AS	Chairman	-	387,173,707	-
M MED STORM INNOVATION AS	Board Member	4,970,331	-83,974	-

Last update: Aug 23, 2024

Related industries8

Direct relationships5

SH
Sveinung Hole1967
SARSIA FOND III AS, SARSIA IV AS
TU
Tore Ulstein1967
STIFTELSEN SINTEF, SINTEF AS
JR
John Robert Zibert1977
RECCURA THERAPEUTICS AS, AVEXXIN ONCOLOGY AS
ØW
Øyvind Weiby Gregersen1970
STIFTELSEN SINTEF, SINTEF AS
AB
Alexandra Bech Gjørv1965
STIFTELSEN SINTEF, SINTEF AS

Shares owned by Erlend Petter Skagseth

Name	Share class	Total operating income	Total equity	Share
M MITOSIS AS	Ordinære aksjer	0	5,454,063	100 % directly
S SARSIA MANAGEMENT AS		24,404,210	8,720,742	15.77 % indirectly
S SARSIA IV AS		0	-31,888	15.77 % indirectly
S SARSIA SEED AS		0	18,259,887	3.25 % indirectly
A AQUILOZ AS		0	-674,876	1.03 % indirectly
A APIM THERAPEUTICS AS		64,960	20,194,781	0.91 % indirectly
S SEA-HAWK NAVIGATION AS		5,326,348	235,971	0.68 % indirectly
P PROPHYLIX PHARMA HOLDING AS		0	19,595,007	0.62 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025